HIGHLIGHTS
- who: Dovile Dekaminaviciute et al. from the Institute of Biotechnology, Vilnius University, VAGraiciuno, Vilnius, Lithuania , Tampere, Finland have published the research: Development and Characterization of New Monoclonal Antibodies against Human Recombinant CA XII, in the Journal: (JOURNAL) of 20/05/2014
- what: The aim of this study was to develop new monoclonal antibodies (MAbs) against human recombinant CA XII and evaluate their diagnostic potential.
SUMMARY
The MAb 6A10 raised against CA XII expressed in lung cancer cells has been shown to inhibit CA XII enzymatic activity and tumor growth in_vitro. Recombinant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.